Compare UTI Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.27
1.87
NAV
₹281.99
₹38.23
Fund Started
01 Aug 2005
25 Jun 2018
Fund Size
₹1106.71 Cr
₹6801.16 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
10.11%
9.76%
3 Year
25.64%
27.80%
5 Year
15.33%
16.99%
Equity
98.21%
97.98%
Cash
1.79%
1.99%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.42% |
Ajanta Pharma Ltd. | 7.04% |
Lupin Ltd. | 5.79% |
Glenmark Pharmaceuticals Ltd. | 4.25% |
Apollo Hospitals Enterprise Ltd. | 3.75% |
Gland Pharma Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.52% |
Dr. Reddy's Laboratories Ltd. | 3.48% |
Alkem Laboratories Ltd. | 3.47% |
Fortis Healthcare Ltd. | 2.98% |
Sun Pharmaceutical Industries Ltd. | 11.21% |
Cipla Ltd. | 9.40% |
Mankind Pharma Ltd. | 7.64% |
Dr. Reddy's Laboratories Ltd. | 6.52% |
Biocon Ltd. | 6.20% |
Divi's Laboratories Ltd. | 5.95% |
Lupin Ltd. | 3.99% |
Aurobindo Pharma Ltd. | 3.70% |
Alkem Laboratories Ltd. | 3.47% |
Syngene International Ltd. | 3.16% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
01 Aug 2005
25 Jun 2018
